Mark Pitney, MBBS

Original Contribution

Twelve-Month Outcomes With a Bioresorbable Everolimus-Eluting Scaffold: Results of the ESHC-BVS Registry at Two Australian Centers

11/15/2015

Daniel Robaei , MBBS;

Liam Back , MBBS;

Sze-Yuan Ooi , MD;

Mark Pitney , MBBS;

Nigel Jepson , MBBS;

The Absorb BVS is a relatively new type of coronary stent designed to provide temporary vessel scaffolding following percutaneous coronary intervention. We report 12-month clinical data on the Absorb BVS from a real-world registry in order to...

The Absorb BVS is a relatively...

11/15/2015

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Mark Pitney, MBBS

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products